119th CONGRESS 1st Session |
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
September 4, 2025
Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Bilirakis, Ms. Pingree, Ms. Tenney, and Mr. Mfume) introduced the following bill; which was referred to the Committee on Energy and Commerce
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
This Act may be cited as the “Stem Cell Therapeutic and Research Reauthorization Act of 2025”.
SEC. 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program.
Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended—
(1) by striking “appropriated $31,009,000” and inserting the following: appropriated—
“(1) $31,009,000”;
(2) in paragraph (1), as so inserted, by striking the period at the end and inserting “; and”; and
(3) by adding at the end the following:
“(2) $33,009,000 for each of fiscal years 2027 through 2031.”.
Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended by striking “2026” and inserting “2031”.